EQSAdhoc Takeda Pharmaceutical Company Limited Key word Forecast Takeda Pharmaceutical Company Limited Notice of the Revised Forecast of Consolidated Financials for FY2023 26Oct2023 0800 CETCEST Disc
EQS-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word: Forecast
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for.
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Takeda TOKYO4502NYSETAK today announced financial results for the first half of fiscal year 2023 six months ended September 30 2023 updating reported and Core forecasts and reconfirming Management Guidance for Core change at CER.
Takeda Pharmaceutical Company Limited: Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.